170 related articles for article (PubMed ID: 36253524)
1. Utility of cell-free DNA from bronchial washing fluid in diagnosis and genomic determination for radiology-suspected pulmonary nodules.
Zhang X; Yu Z; Xu Y; Chao Y; Hu Q; Li C; Ye M; Zhu X; Cui L; Bai J; Gong Y; Guan Y; Zhou M; Huang J; Zhang H; Ren T; Shen Q; Wang K; Hou Y; Xia X; Pu X; Carbone DP; Zhang X
Br J Cancer; 2022 Dec; 127(12):2154-2165. PubMed ID: 36253524
[TBL] [Abstract][Full Text] [Related]
2. Identifying Genomic Alterations in Small Cell Lung Cancer Using the Liquid Biopsy of Bronchial Washing Fluid.
Zhai J; Han S; Guo Q; Shan B; Wang J; Guo Y; Tong G; Zhao C; Li Y; Han Q; An X; Yue R; Wang L; Guo T; Liu Z; Xu Y; Li J; Yang W
Front Oncol; 2021; 11():647216. PubMed ID: 33987084
[No Abstract] [Full Text] [Related]
3. [Detection of epidermal growth factor receptor mutations using bronchial washing fluid in lung cancer patients with negative results by rapid on-site evaluation].
Zhang XY; Jiang ZZ; Li C; Ye MS; Hu Q; Zhao YC; Zhang DY; Gong ZY; Hou YY; Zhang X
Zhonghua Bing Li Xue Za Zhi; 2018 Dec; 47(12):915-919. PubMed ID: 30522171
[No Abstract] [Full Text] [Related]
4. Compared to plasma, bronchial washing fluid shows higher diagnostic yields for detecting EGFR-TKI sensitizing mutations by ddPCR in lung cancer.
Lee SH; Kim EY; Kim T; Chang YS
Respir Res; 2020 Jun; 21(1):142. PubMed ID: 32517757
[TBL] [Abstract][Full Text] [Related]
5. Bronchial Washing Fluid Versus Plasma and Bronchoscopy Biopsy Samples for Detecting Epidermal Growth Factor Receptor Mutation Status in Lung Cancer.
Zhang X; Li C; Ye M; Hu Q; Hu J; Gong Z; Li J; Zhao X; Xu Y; Zhang D; Hou Y; Zhang X
Front Oncol; 2021; 11():602402. PubMed ID: 33828971
[TBL] [Abstract][Full Text] [Related]
6. Assessment of Anti-tumor Efficacy of Osimertinib in Non-Small Cell Lung Cancer Patients by Liquid Biopsy Using Bronchoalveolar Lavage Fluid, Plasma, or Pleural Effusion.
Kim YJ; Ji WJ; Lee JC; Chun SM; Choi CM
Cancer Res Treat; 2022 Oct; 54(4):985-995. PubMed ID: 35038824
[TBL] [Abstract][Full Text] [Related]
7. Increased levels of albumin in bronchial washing fluid of patients with bronchial carcinoma. Could albumin be considered as a tumor marker?
Charokopos N; Leotsinidis M; Tsiamita M; Kalofonos HP; Vasillakos P; Christofidou M; Spiropoulos K
Int J Biol Markers; 2004; 19(4):316-21. PubMed ID: 15646839
[TBL] [Abstract][Full Text] [Related]
8. Cell-free DNA from bile outperformed plasma as a potential alternative to tissue biopsy in biliary tract cancer.
Gou Q; Zhang CZ; Sun ZH; Wu LG; Chen Y; Mo ZQ; Mai QC; He J; Zhou ZX; Shi F; Cui W; Zou W; Lv L; Zhuang WH; Xu RD; Li WK; Zhang J; Du HW; Xiang JX; Wang HZ; Hou T; Li ST; Li Y; Chen XM; Zhou ZJ
ESMO Open; 2021 Dec; 6(6):100275. PubMed ID: 34653800
[TBL] [Abstract][Full Text] [Related]
9. Treatment of Non-Small-Cell Lung Cancer Based on Circulating Cell-Free DNA and Impact of Variation Allele Frequency.
Bustamante Alvarez JG; Janse S; Owen DH; Kiourtsis S; Bertino EM; He K; Carbone DP; Otterson GA
Clin Lung Cancer; 2021 Jul; 22(4):e519-e527. PubMed ID: 33414052
[TBL] [Abstract][Full Text] [Related]
10. Liquid biopsy of fine-needle aspiration supernatant for lung cancer genotyping.
Guibert N; Tsukada H; Hwang DH; Chambers E; Cibas ES; Bale T; Supplee J; Ulrich B; Sholl LM; Paweletz CP; Oxnard GR
Lung Cancer; 2018 Aug; 122():72-75. PubMed ID: 30032849
[TBL] [Abstract][Full Text] [Related]
11. Performance of the Xpert® MTB/RIF assay in the rapid diagnosis of tracheobronchial tuberculosis using bronchial washing fluid.
Song YH; Li Q; Ma LP; Liu RM; Jiang GL; Li Q; Gao MQ
J Int Med Res; 2020 Oct; 48(10):300060520921640. PubMed ID: 33045875
[TBL] [Abstract][Full Text] [Related]
12. Tumor-derived DNA from pleural effusion supernatant as a promising alternative to tumor tissue in genomic profiling of advanced lung cancer.
Tong L; Ding N; Tong X; Li J; Zhang Y; Wang X; Xu X; Ye M; Li C; Wu X; Bao H; Zhang X; Hong Q; Song Y; Shao YW; Bai C; Zhou J; Hu J
Theranostics; 2019; 9(19):5532-5541. PubMed ID: 31534501
[TBL] [Abstract][Full Text] [Related]
13. Distinct profile of cell-free DNA in malignant pleural effusion of non-small cell lung cancer and its impact on clinical genetic testing.
Yu Y; Qian J; Shen L; Ji W; Lu S
Int J Med Sci; 2021; 18(6):1510-1518. PubMed ID: 33628109
[TBL] [Abstract][Full Text] [Related]
14. Unique genetic profiles from cerebrospinal fluid cell-free DNA in leptomeningeal metastases of EGFR-mutant non-small-cell lung cancer: a new medium of liquid biopsy.
Li YS; Jiang BY; Yang JJ; Zhang XC; Zhang Z; Ye JY; Zhong WZ; Tu HY; Chen HJ; Wang Z; Xu CR; Wang BC; Du HJ; Chuai S; Han-Zhang H; Su J; Zhou Q; Yang XN; Guo WB; Yan HH; Liu YH; Yan LX; Huang B; Zheng MM; Wu YL
Ann Oncol; 2018 Apr; 29(4):945-952. PubMed ID: 29346604
[TBL] [Abstract][Full Text] [Related]
15. Cell-free DNA analysis in healthy individuals by next-generation sequencing: a proof of concept and technical validation study.
Alborelli I; Generali D; Jermann P; Cappelletti MR; Ferrero G; Scaggiante B; Bortul M; Zanconati F; Nicolet S; Haegele J; Bubendorf L; Aceto N; Scaltriti M; Mucci G; Quagliata L; Novelli G
Cell Death Dis; 2019 Jul; 10(7):534. PubMed ID: 31296838
[TBL] [Abstract][Full Text] [Related]
16. Genetic Profiling of Cell-Free DNA From Pleural Effusion in Advanced Lung Cancer as a Surrogate for Tumor Tissue and Revealed Additional Clinical Actionable Targets.
Tu HY; Li YS; Bai XY; Sun YL; Zheng MY; Ke EE; Liao RQ; Jiang BY; Lin JX; Huang J; Xu BF; Yang JJ; Zhang XC; Zhou Q; Wang BC; Chen HJ; Tong X; Yu R; Wu X; Zhu D; Wu YL
Clin Lung Cancer; 2022 Mar; 23(2):135-142. PubMed ID: 34645582
[TBL] [Abstract][Full Text] [Related]
17. Differences in the genomic profiles of cell-free DNA between plasma, sputum, urine, and tumor tissue in advanced NSCLC.
Wu Z; Yang Z; Li CS; Zhao W; Liang ZX; Dai Y; Zhu Q; Miao KL; Cui DH; Chen LA
Cancer Med; 2019 Mar; 8(3):910-919. PubMed ID: 30767431
[TBL] [Abstract][Full Text] [Related]
18. Genomic alterations of plasma cell-free DNAs in small cell lung cancer and their clinical relevance.
Du M; Thompson J; Fisher H; Zhang P; Huang CC; Wang L
Lung Cancer; 2018 Jun; 120():113-121. PubMed ID: 29748005
[TBL] [Abstract][Full Text] [Related]
19. Quantitative analysis of a novel DNA hypermethylation panel using bronchial specimen for lung cancer diagnosis.
Dou M; Li D; Zhu M; Guo W; Miao C; Li M; Xue Y; He R; Jiang N; Ge D; Hu Q; Shao Y; Hou Y; Wang X; Huang X; Liu T; Wang Q; Wang Y; Sun J; Wang W; Song Y; Hu J; Huang Q
Int J Cancer; 2023 Sep; 153(5):1096-1107. PubMed ID: 37232006
[TBL] [Abstract][Full Text] [Related]
20. Cytology of bronchial biopsy rinse fluid to improve the diagnostic yield for lung cancer.
Rosell A; Monsó E; Lores L; Vilà X; Llatjós M; Ruiz J; Morera J
Eur Respir J; 1998 Dec; 12(6):1415-8. PubMed ID: 9877501
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
